Clinical Trials in Philadelphia

Showing 3041-3060 of 20,904 trials

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

NCT06872905

The study will assess the safety and effectiveness of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis ("VBX Device" or also referred to as "VBX Stent Graft") in a post approval setting and evaluate the quality of the use in covered endovascular reconstruction of the aortic bifurcation (CERAB) to treat Aortoiliac Occlusive Disease (AIOD).

Aortoiliac Occlusive Disease

W.L.Gore & Associates158 participantsStarted May 2025

Fresno, California, United States • Rochester, Minnesota, United States • Camden, New Jersey, United States +15 more locations

Active Not RecruitingPhase 3< 1 mile

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial

NCT03496883

The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit, will improve outcomes at 180 days as measured by the Modified Rankin Score (mRS) and decrease ongoing bleeding as compared to standard therapy.

Intracerebral Hemorrhage

Joseph Broderick, MD860 participantsStarted Dec 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Baldwin Park, California, United States +85 more locations

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial

Find Trials by Condition in Philadelphia

Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)

Randomized Trial of Early Hemodynamic Management of Patients Following Acute Spinal Cord Injury

Fecal Microbiota Transplant National Registry

Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer

Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer

A Study to Learn About a Vaccine Against E Coli in Healthy Adults

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)

A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes

EXoPERT EMERALD Clinical Study

Precise Procedural and PCI Plan (P4)

Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET

Study of GS-0151 in Participants With Rheumatoid Arthritis

A Study to Assess the Efficacy and Safety of HMI-115 in Subjects With Endometriosis-Associated Pain

Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab

D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection

5-Year Global Study on MAST™ Minimally Invasive Fusion Procedures to Treat Degenerative Lumbar Spine (MASTERS-D2)